| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |